Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

MADIT-II and its implications.

Moss AJ; Multicenter Automatic Defibrillator Implantation Trial..

Eur Heart J. 2003 Jan;24(1):16-8. No abstract available.

PMID:
12559932
2.

Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.

Bunch TJ, Hohnloser SH, Gersh BJ.

Circulation. 2007 May 8;115(18):2451-7. Review. No abstract available.

3.

Implantable devices benefit patients with cardiovascular diseases.

Schron EB, Domanski MJ.

J Cardiovasc Nurs. 2003 Nov-Dec;18(5):337-42. Review.

PMID:
14680335
4.

MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy.

Reynolds MR, Josephson ME.

Circulation. 2003 Oct 14;108(15):1779-83. Review. No abstract available.

5.
6.

Implantable cardioverter-defibrillators: a new preventive medical option.

Glatter KA, Young JN, McElvany MD.

Prev Cardiol. 2006 Winter;9(1):49-53; quiz 54-5. Review.

7.

Sudden death prevention with implantable devices.

Passman R, Kadish A.

Circulation. 2007 Jul 31;116(5):561-71. Review. No abstract available.

8.

Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?

Armoundas AA, Hohnloser SH, Ikeda T, Cohen RJ.

Nat Clin Pract Cardiovasc Med. 2005 Oct;2(10):522-8. Review.

PMID:
16186850
9.

[Physiopathology of coronary heart disease--therapeutic implications].

Schulz R, Heusch G.

Anasthesiol Intensivmed Notfallmed Schmerzther. 1999 Mar;34(3):172-5. Review. German. No abstract available.

PMID:
10234412
10.

MADIT-I and MADIT-II.

Moss AJ.

J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S96-8. Review.

PMID:
12950528
12.

Approach to the patient with prior bypass surgery.

Nguyen T, Pham L, Cheem TH, Douglas JS, Hermiller J, Grines C.

J Interv Cardiol. 2004 Oct;17(5):339-46. Review. No abstract available.

PMID:
15491339
13.

Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?

Lekas M, Lekas P, Latter DA, Kutryk MB, Stewart DJ.

Curr Opin Cardiol. 2006 Jul;21(4):376-84. Review.

PMID:
16755208
14.

Device therapy for heart failure.

Boehmer JP.

Am J Cardiol. 2003 Mar 20;91(6A):53D-59D. Review.

PMID:
12670643
15.

Silent myocardial ischemia: concepts and controversies.

Almeda FQ, Kason TT, Nathan S, Kavinsky CJ.

Am J Med. 2004 Jan 15;116(2):112-8. Review.

PMID:
14715325
16.

[Coronary revascularization. State of the art].

Alfonso F, Bermejo J, Segovia J.

Rev Esp Cardiol. 2005 Feb;58(2):194-7. Review. Spanish. No abstract available.

17.

[Ischemic cardiomyopathy: possibilities of surgical treatment].

Benetis R, Simukauskiene A, Jankauskiene L, Kavoliƫniene A.

Medicina (Kaunas). 2007;43(11):909-17. Review. Lithuanian.

18.

Implantable cardioverter-defibrillators in cardiovascular care: technologic advances and new indications.

Rao BH, Saksena S.

Curr Opin Crit Care. 2003 Oct;9(5):362-8. Review.

PMID:
14508148
19.

Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction.

Goldberg LR, Jessup M.

Circulation. 2006 Jun 20;113(24):2851-60. Review. No abstract available.

20.

Putting the benefits of percutaneous coronary revascularization into perspective: from trials to guidelines.

Sharma K, Eisenberg MJ.

Curr Cardiol Rep. 2008 Sep;10(5):393-401. Review.

PMID:
18715536

Supplemental Content

Support Center